{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:14:48Z","timestamp":1794647688178,"version":"4.9.1"},"reference-count":41,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T00:00:00Z","timestamp":1656374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Tabula Rasa HealthCare Group"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Healthcare"],"abstract":"<jats:p>This study aimed to compare the clinical outcomes of pharmacist-provided medication therapy management (MTM) services as compared to no MTM services (i.e., standard of care) on outpatient clinical outcomes for patients with diabetes, hypertension, or dyslipidemia. A systematic literature review of PubMed, EMBASE, Cochrane library, International Pharmaceutical Abstracts, PsycINFO, Scopus, CINAHL electronic databases, grey literature, websites, and journals, was conducted from 1 January 2005\u201320 July 2021. The search field contained a combination of keywords and MeSH terms such as: \u201cmedication therapy management\u201d, \u201cpharmacist\u201d, \u201ctreatment outcomes\u201d. Studies published in United States, included adults \u226518 years old who received at least one pharmacist-provided MTM consultation and at least one group who received no MTM, and reported pre-specified clinical outcomes for diabetes mellitus, hypertension, or dyslipidemia were included. Of 849 studies identified, eight were included (cohort studies = 6, randomized controlled trials = 2). Clinical outcomes improved with MTM interventions, as evidenced by statistically significant changes in at least one of the three chronic conditions in most studies. Improvements were observed for diabetes outcomes (n = 4 studies), hypertension outcomes (n = 4 studies), and dyslipidemia outcomes (n = 3 studies). Overall, this study indicated that pharmacist delivered MTM services (versus no MTM services) can improve clinical outcomes for patients with diabetes, hypertension, and dyslipidemia.<\/jats:p>","DOI":"10.3390\/healthcare10071207","type":"journal-article","created":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T23:59:22Z","timestamp":1656460762000},"page":"1207","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["A Systematic Review of Clinical Outcomes from Pharmacist Provided Medication Therapy Management (MTM) among Patients with Diabetes, Hypertension, or Dyslipidemia"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3786-2846","authenticated-orcid":false,"given":"Srujitha","family":"Marupuru","sequence":"first","affiliation":[{"name":"R. Ken Coit College of Pharmacy, The University of Arizona, Tucson, AZ 85721, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Roether","sequence":"additional","affiliation":[{"name":"R. Ken Coit College of Pharmacy, The University of Arizona, Tucson, AZ 85721, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. J.","family":"Guimond","sequence":"additional","affiliation":[{"name":"R. Ken Coit College of Pharmacy, The University of Arizona, Tucson, AZ 85721, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7654-0810","authenticated-orcid":false,"given":"Chris","family":"Stanley","sequence":"additional","affiliation":[{"name":"R. Ken Coit College of Pharmacy, The University of Arizona, Tucson, AZ 85721, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Pesqueira","sequence":"additional","affiliation":[{"name":"R. Ken Coit College of Pharmacy, The University of Arizona, Tucson, AZ 85721, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9903-5996","authenticated-orcid":false,"given":"David R.","family":"Axon","sequence":"additional","affiliation":[{"name":"R. Ken Coit College of Pharmacy, The University of Arizona, Tucson, AZ 85721, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,6,28]]},"reference":[{"key":"ref_1","unstructured":"Joint Commission of Pharmacy Practitioners (2022, January 24). The Pharmacists\u2019 Patient Care Process. Available online: https:\/\/jcpp.net\/wp-content\/uploads\/2016\/03\/PatientCareProcess-with-supporting-organizations.pdf."},{"key":"ref_2","unstructured":"(2022, January 24). H.R.1\u2014108th Congress (2003\u20132004): Medicare Prescription Drug, Improvement, and Modernization Act of 2003, Available online: https:\/\/www.congress.gov\/bill\/108th-congress\/house-bill\/1."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1331\/1544345055001274","article-title":"Definition of Medication Therapy Management: Development of Professionwide Consensus","volume":"45","author":"Bluml","year":"2005","journal-title":"J. Am. Pharm. Assoc."},{"key":"ref_4","unstructured":"Chavez-Valdez, A.L. (2022, January 24). Release of the CY 2020 MTM Program Submission Module in HPMS a CMS-Approved MTM Program Is One of Several Required Elements in the Development of a Medicare Part D Sponsor\u2019s Bid. Annually, Sponsors Must Submit an MTM Program, Available online: https:\/\/www.cms.gov\/Medicare\/Prescription-Drug-Coverage\/PrescriptionDrugCovContra\/Downloads\/Memo-Contract-Year-2020-Medication-Therapy-Management-MTM-Program-Submission-v-041019-.pdf."},{"key":"ref_5","unstructured":"The Centers for Medicare & Medicaid Services (2022, January 24). 2016 Final Advance Notice, Available online: https:\/\/www.cms.gov\/Medicare\/HealthPlans\/MedicareAdvtgSpecRateStats\/Downloads\/Advance2016.pdf."},{"key":"ref_6","first-page":"18","article-title":"Analysis of Pharmacist-Provided Medication Therapy Management(MTM) Services in Community Pharmacies over 7 Years","volume":"15","author":"Barnett","year":"2009","journal-title":"J. Manag. Care Pharm."},{"key":"ref_7","first-page":"688","article-title":"Comparison of Medication Therapy Management Services and Their Effects on Health Care Utilization and Medication Adherence","volume":"25","author":"Ferries","year":"2019","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1310\/hpj4805-380","article-title":"Can the Targeted Use of a Discharge Pharmacist Significantly Decrease 30-Day Readmissions?","volume":"48","author":"Pal","year":"2013","journal-title":"Hosp. Pharm."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/jamainternmed.2014.5841","article-title":"Medication Therapy Management Interventions in Outpatient Settings","volume":"175","author":"Viswanathan","year":"2015","journal-title":"JAMA Intern. Med."},{"key":"ref_10","unstructured":"(2022, January 24). National Institute of Diabetes and Digestive and Kidney Diseases. Diabetes. U.S. Department of Health and Human Services, Available online: https:\/\/www.niddk.nih.gov\/health-information\/diabetes."},{"key":"ref_11","unstructured":"American Diabetes Association (2022, January 24). Understanding A1c. Available online: https:\/\/www.diabetes.org\/a1c\/diagnosis."},{"key":"ref_12","unstructured":"Cleveland Clinic (2022, January 24). Diabetes: An Overview. Available online: https:\/\/my.clevelandclinic.org\/health\/diseases\/7104-diabetes-mellitus-an-overview."},{"key":"ref_13","unstructured":"Centers for Disease Control and Prevention (2022, January 24). Estimating Hypertension Prevalence, Treatment, and Control among U.S. Adults. Million Hearts, Available online: https:\/\/millionhearts.hhs.gov\/data-reports\/hypertension-prevalence.html."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults","volume":"71","author":"Whelton","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_15","unstructured":"Pappan, N., and Rehman, A. (2022, February 06). Dyslipidemia, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK560891\/."},{"key":"ref_16","unstructured":"Centers for Disease Control and Prevention (2022, June 27). Total and high-density lipoprotein cholesterol in adults: United States, 2015\u20132018, Available online: https:\/\/www.cdc.gov\/nchs\/data\/databriefs\/db363-h.pdf."},{"key":"ref_17","unstructured":"Centers for Disease Control and Prevention (2022, June 27). Community Pharmacists and Medication Therapy Management. Centers for Disease Control and Prevention, Available online: https:\/\/www.cdc.gov\/dhdsp\/pubs\/guides\/best-practices\/pharmacist-mtm.htm."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews","volume":"372","author":"Page","year":"2021","journal-title":"Br. Med. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A Revised Tool for Assessing Risk of Bias in Randomised Trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: A Tool for Assessing Risk of Bias in Non-Randomised Studies of Interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.clinthera.2014.06.030","article-title":"Primary Care\u2013Based, Pharmacist\u2013Physician Collaborative Medication-Therapy Management of Hypertension: A Randomized, Pragmatic Trial","volume":"36","author":"Hirsch","year":"2014","journal-title":"Clin. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1331\/JAPhA.2009.08164","article-title":"Evaluation of a Hypertension Medication Therapy Management Program in Patients with Diabetes","volume":"49","author":"Planas","year":"2009","journal-title":"J. Am. Pharm. Assoc."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1089\/pop.2012.0023","article-title":"Optimal Diabetes Care Outcomes Following Face-To-Face Medication Therapy Management Services","volume":"16","author":"Brummel","year":"2013","journal-title":"Popul. Health Manag."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1331\/JAPhA.2009.09016","article-title":"A Medication Therapy Management Program\u2019s Impact on Low-Density Lipoprotein Cholesterol Goal Attainment in Medicare Part D Patients with Diabetes","volume":"49","author":"Fox","year":"2009","journal-title":"J. Am. Pharm. Assoc."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1345\/aph.1L591","article-title":"Mitigation of Medication Mishaps via Medication Therapy Management","volume":"43","author":"Pindolia","year":"2009","journal-title":"Ann. Pharmacother."},{"key":"ref_26","first-page":"423","article-title":"The Effect of Clinical Pharmacist-Led Comprehensive Medication Management on Chronic Disease State Goal Attainment in a Patient-Centered Medical Home","volume":"24","author":"Prudencio","year":"2018","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/0145721715587563","article-title":"Assessing the Effectiveness of Pharmacist-Directed Medication Therapy Management in Improving Diabetes Outcomes in Patients with Poorly Controlled Diabetes","volume":"41","author":"Skinner","year":"2015","journal-title":"Diabetes Educ."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/1060028018794860","article-title":"Impact of a Medication Therapy Management Clinic on Glycosylated Hemoglobin, Blood Pressure, and Resource Utilization","volume":"53","author":"Tilton","year":"2018","journal-title":"Ann. Pharmacother."},{"key":"ref_29","unstructured":"(2022, January 24). Measurement Resources. MN Community Measurement. Measurement Resources. Available online: https:\/\/mncm.org\/measurement-resources\/#:~:text=The%20D5%20is%20a%20set."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.2042-7174.2002.tb00592.x","article-title":"A Randomised Controlled Trial of a Pharmaceutical Care Programme in High-Risk Diabetic Patients in an Outpatient Clinic","volume":"10","author":"Clifford","year":"2002","journal-title":"Int. J. Pharm. Pract."},{"key":"ref_31","first-page":"632","article-title":"Provision of Medication Therapy Management by Pharmacists to Patients with Type-2 Diabetes Mellitus in a Federally Qualified Health Center","volume":"42","author":"Ndefo","year":"2017","journal-title":"Pharm. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/193229680900300120","article-title":"Pharmacists\u2019 Role in Improving Diabetes Medication Management","volume":"3","author":"Smith","year":"2009","journal-title":"J. Diabetes Sci. Technol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1177\/0897190020903573","article-title":"Pharmacist Interventions in the Management of Blood Pressure Control and Adherence to Antihypertensive Medications: A Systematic Review of Randomized Controlled Trials","volume":"34","author":"Reeves","year":"2020","journal-title":"J. Pharm. Pract."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2146\/ajhp090047","article-title":"An Employer-Based, Pharmacist Intervention Model for Patients with Type 2 Diabetes","volume":"67","author":"Iyer","year":"2010","journal-title":"Am. J. Health-Syst. Pharm."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"200350","DOI":"10.5888\/pcd17.200350","article-title":"Pharmacy Contributions to Improved Population Health: Expanding the Public Health Roundtable","volume":"17","author":"Strand","year":"2020","journal-title":"Prev. Chronic Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.5688\/aj7410S7","article-title":"Pharmacists\u2019 Contributions to Primary Care in the United States Collaborating to Address Unmet Patient Care Needs: The Emerging Role for Pharmacists to Address the Shortage of Primary Care Providers","volume":"74","author":"Manolakis","year":"2010","journal-title":"Am. J. Pharm. Educ."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/1742395307081501","article-title":"Supporting Self-Management for Patients with Complex Medical Needs: Recommendations of a Working Group","volume":"3","author":"Bayliss","year":"2007","journal-title":"Chronic Illn."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.cjca.2017.12.005","article-title":"Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms","volume":"34","author":"Petrie","year":"2018","journal-title":"Can. J. Cardiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.2337\/dc11-0735","article-title":"Diabetes Performance Measures: Current Status and Future Directions","volume":"34","author":"Bodkin","year":"2011","journal-title":"Diabetes Care"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1177\/2047487319872015","article-title":"Risk Factor Reduction in Type 2 Diabetes Demands a Multifactorial Approach","volume":"26","author":"Ferrannini","year":"2019","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e2036725","DOI":"10.1001\/jamanetworkopen.2020.36725","article-title":"Assessment of Interprofessional Collaborative Practices and Outcomes in Adults with Diabetes and Hypertension in Primary Care: A Systematic Review and Meta-Analysis","volume":"4","author":"Lee","year":"2021","journal-title":"JAMA Netw. Open"}],"container-title":["Healthcare"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9032\/10\/7\/1207\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:39:26Z","timestamp":1760139566000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9032\/10\/7\/1207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,28]]},"references-count":41,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["healthcare10071207"],"URL":"https:\/\/doi.org\/10.3390\/healthcare10071207","relation":{},"ISSN":["2227-9032"],"issn-type":[{"value":"2227-9032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,28]]}}}